Gayle Blatt and Wendy Behan, Casey Gerry's pharmaceutical litigation specialists, have extensive experience in helping people injured by dangerous drugs. Ms Blatt is a Casey Gerry partner with a track record of successful litigation against manufacturers of dangerous drugs and medical devices. She has figured prominently in national pharmaceutical litigation involving Propulsid, the Sulzer hip, L-Tryptophan, Baycol, Metabolife, and Rezulin. She has served on court-appointed steering committees on statewide and/or national coordinated litigation in the Sulzer, Baycol and Metabolife cases.


Ms. Blatt was named a San Diego 2007 Super Lawyer and one of the Top 25 Women Lawyers in San Diego. For ten years she served on the board of the Consumer Attorneys of San Diego, the plaintiffs' trial lawyer organization, and she served as its President in 2007. She also serves on the Board of Governors of the Consumer Attorneys of California and is a longtime member of the American Association of Justice.
Wendy Behan works closely with Ms Blatt on the firm's pharmaceutical litigation cases, including Rezulin (a diabetes medication now withdrawn from the market because of liver toxicity), Propulsid (a heartburn medication whose serious side effects led to its withdrawal from the US market), and Baycol (a cholesterol lowering drug which caused serious muscle damage and death in some patients). She has also worked with Ms Blatt on cases involving over the counter supplements with dangerous side effects such as Metabolife and L-Tryptophan.
Ms Blatt and Ms Behan are currently evaluating claims related to Gadolinium.
Casey Gerry has a long history of successful litigation against dangerous drugs and defective medical devices. Ms Blatt and Ms Behan work with a team of experienced pharmaceutical lawyers and paralegals. Casey Gerry's also maintains its own staff of full time investigators who work closely with clients and their families, and are able follow up with healthcare professionals to gather information about your medical status and exposure to Gadolinium Based Contrast Agents.
If you or a loved one has received a diagnosis of Nephrogenic Systemic Fibrosis it is important to act quickly to secure the appropriate medical care, and also to assure that vital information regarding your treatment and your exposure to Gadolinium Based Contrast Agents is documented. Pharmaceutical attorneys Gayle Blatt and Wendy Behan and their colleagues at Casey Gerry are dedicated professionals with decades of experience who can take prompt and effective steps to help you and your family through all aspects of a claim for this debilitating disease.